Abbott Laboratories (ABT)
113.22
-0.39
(-0.34%)
USD |
NYSE |
Mar 04, 10:17
Abbott Laboratories Cash from Investing (Quarterly) : -913.00M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Boston Scientific Corp. | -512.00M |
| Intuitive Surgical, Inc. | -209.40M |
| Insulet Corp. | -152.80M |
| ResMed, Inc. | -50.94M |
| Baxter International, Inc. | -198.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 3.315B |
| Cash from Financing (Quarterly) | -1.397B |
| Free Cash Flow | 7.395B |
| Free Cash Flow Per Share (Quarterly) | 1.503 |
| Free Cash Flow to Equity (Quarterly) | 1.431B |
| Free Cash Flow to Firm (Quarterly) | 2.728B |
| Free Cash Flow Yield | 3.74% |